Moreover, Paclitaxel sensitivity is lower in the mutant CSMD1 group and CSMD1 mutation is associated with tumor invasion of immune cells with more follicular helper T cells and fewer resting state dendritic cells. This evidence concerns the gene CSMD1 and neoplasm.